| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |